Evolution Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Evolution Advisers's ABBV Position: Q3 2026 in Review
Evolution Advisers sold out of AbbVie (ABBV) in Q3 2026, closing a stake of 5 shares — an estimated $1K sold.
Evolution Advisers first reported a position in ABBV in Q2 2024 and held it in 4 quarters. The position peaked at $1K in Q2 2026. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Evolution Advisers reported no remaining AbbVie position as of Q3 2026 after selling out during the quarter.
- Evolution Advisers sold 5 AbbVie shares in Q3 2026, an estimated $1K.
- Evolution Advisers first reported a position in AbbVie in Q2 2024 and held it in 4 quarters.
- Evolution Advisers's AbbVie position peaked at $1K in Q2 2026.
- 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Evolution Advisers's 13F filing for Q3 2026, filed 6 Nov 2026.